ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
61 hedge funds and large institutions have $8.79M invested in Oncternal Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
61
Holding in Top 10
–
Calls
$65K
Puts
–
Top Buyers
| 1 | +$649K | |
| 2 | +$300K | |
| 3 | +$183K | |
| 4 |
Two Sigma Advisers
New York
|
+$143K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$112K |
Top Sellers
| 1 | -$1.29M | |
| 2 | -$635K | |
| 3 | -$334K | |
| 4 |
Goldman Sachs
New York
|
-$161K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$135K |